Clinical Trials in San Francisco

Showing 3181-3200 of 6,211 trials

Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma

NCT02844439

This is a multicenter, Phase 2 study to assess the activity of tesevatinib in patients with recurrent glioblastoma.

GlioblastomaRecurrent GlioblastomaBrain Tumor

Kadmon Corporation, LLC40 participantsStarted Jun 2016

Tucson, Arizona, United States • Duarte, California, United States • San Francisco, California, United States +8 more locations

TERMINATED< 1 mile

A Cohort Study of Operationally Tolerant Allograft Recipients

NCT02743793

Antirejection medicines, also known as immunosuppressive drugs, are prescribed to organ transplant recipients to prevent their bodies from rejecting the new organ. Some organ transplant recipients can stop taking anti-rejection medicines without rejecting their transplanted organ (this is called 'tolerance'). The purpose of this study will collect samples and data from 'tolerant' liver or kidney transplant recipients in order to find out: The purpose of this study is to collect samples and data in order to find out: * How long liver or kidney transplant recipients can remain tolerant; * What happens in the tolerant recipient's body over time; and * If there are patterns in the body that are linked to tolerance.

Kidney TransplantLiver Transplant

National Institute of Allergy and Infectious Diseases (NIAID)41 participantsStarted Jun 2016

San Francisco, California, United States • Atlanta, Georgia, United States • Chicago, Illinois, United States +2 more locations

Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma

A Cohort Study of Operationally Tolerant Allograft Recipients

Find Trials by Condition in San Francisco

A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast Cancer

Evaluating Multivariate MRI Maps of Body Awareness

Defibrotide TMA Prophylaxis Pilot Trial

Assisted Peritoneal Dialysis: A Feasibility Study

Evaluation of the Optimal Transition Program

A Randomized Controlled Trial of Ultrasound-guided Platelet-Rich-Plasma (PRP) Injection Versus Extracorporeal Shock Wave Therapy (ESWT) for Great Trochanter Pain Syndrome (GTPS) With Gluteus Medius or Minimus Tendinopathy

The Natural History of Wounds in Patients With Dystrophic Epidermolysis Bullosa (DEB)

A Study of PTR-01 in Recessive Dystrophic Epidermolysis Bullosa

Adverse Metabolic Effects of Dietary Sugar

Outreach and Choice in Colorectal Cancer Screening

Onduo Virtual Diabetes Clinic Study

Cerebral Blood Flow Evaluation With Trancranial Doppler After Interscalene Nerve Block

Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects

Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)

An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential Hypertension

Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)

Assessing Symptomatic Clinical Episodes in Depression

A Phase 1/2, Open-label, Dose Finding Study to Evaluate CC-122 in Combination With Ibrutinib and Obinutuzumab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma